The Swiss Approach - feasibility of a national low-dose CT lung cancer screening program. - Publication

Publication

The Swiss Approach - feasibility of a national low-dose CT lung cancer screening program.

Journal Paper/Review - Apr 14, 2022

Jungblut Lisa, von Garnier Christophe, Puhan Milo, Tomonaga Yuki, Kaufmann Cornel, Azzola Andrea, Bürgi Urs, Bremerich Jens, Brutsche Martin, Christe Andreas, Ebner Lukas, Heverhagen Johannes T, Eich Christine, Franzen Daniel, Schmitt-Opitz Isabelle, Schneiter Didier, Spieldenner Jörg, Horwath Nigel, Kohler Malcolm, Weder Walter, Lovis Alban, Meuli Reto, Menig Matthias, Beigelmann-Aubry Catherine, Niemann Tilo, Stöhr Susanna, Vock Peter, Senn Oliver, Neuner-Jehle Stefan, Selby Kevin, Laures Simin, Otto Sebastian, Frauenfelder Thomas

Citation

Jungblut L, von Garnier C, Puhan M, Tomonaga Y, Kaufmann C, Azzola A, Bürgi U, Bremerich J, Brutsche M, Christe A, Ebner L, Heverhagen J, Eich C, Franzen D, Schmitt-Opitz I, Schneiter D, Spieldenner J, Horwath N, Kohler M, Weder W, Lovis A, Meuli R, Menig M, Beigelmann-Aubry C, Niemann T, Stöhr S, Vock P, Senn O, Neuner-Jehle S, Selby K, Laures S, Otto S, Frauenfelder T. The Swiss Approach - feasibility of a national low-dose CT lung cancer screening program. Swiss Med Wkly 2022; 152

Type

Journal Paper/Review (English)

Journal

Swiss Med Wkly 2022; 152

Publication Date

Apr 14, 2022

Issn Electronic

1424-3997

Brief description/objective

Lung cancer is the leading cause of cancer-related deaths in Switzerland. Despite this, there is no lung cancer screening program in the country. In the United States, low-dose computed tomography (LDCT) lung cancer screening is partially established and endorsed by guidelines. Moreover, evidence is growing that screening reduces lung cancer-related mortality and this was recently shown in a large European randomized controlled trial. Implementation of a lung cancer screening program, however, is challenging and depends on many country-specific factors. The goal of this article is to outline a potential Swiss lung cancer screening program.